What is the latest RPGLIFE stock price?
The latest stored price for RPGLIFE is Rs 2,997.90 as of 2026-07-21.
gimli
RPGLIFE stock AI analysis
RPGLIFE Stock AI Analysis: Price, PE, 50DMA, Shareholding and Peers
RPG LIFE SCIENCES LTD is a small-cap stock in Healthcare. This Gimli page shows the latest available RPGLIFE price, returns, 50DMA/200DMA trend, PE, ROE, ROCE, financials, shareholding pattern, and industry peers for Indian stock screening research.
Price
₹2,997.90
1W return
+9.40%
1M return
+31.64%
3M return
+49.99%
6M return
+36.05%
1Y return
+15.45%
Market cap
₹4,958.23 cr
PE
43.05
PB
8.19
ROE
+20.28%
ROCE
+16.87%
RSI
73.19
Turnover
₹10.57 cr
Why it can matter in screens
- Momentum: RPGLIFE is above 50DMA, above 200DMA; RSI is 73.19.
- Returns: 1D -0.64%, 1W +9.40%, 1M +31.64%, 3M +49.99%, 1Y +15.45%.
- Trend levels: 52W high ₹3,017.10, 52W low ₹1,744.00, off high -0.64%.
- Liquidity: latest turnover is ₹10.57 cr; volume vs 20D is +0.80%.
- Valuation/profitability: PE 43.05, PB 8.19, ROE +20.28%, ROCE +16.87%.
- Growth: 3Y sales CAGR +11.59%, 3Y profit CAGR +19.41%.
Quick Answers
Is RPGLIFE above its 50DMA and 200DMA?
RPGLIFE is above 50DMA, above 200DMA. The latest 50DMA is 2,384.70 and the latest 200DMA is 2,213.69.
What are RPGLIFE PE, ROE and ROCE?
RPGLIFE has PE 43.05, ROE +20.28%, and ROCE +16.87% in Gimli's latest available snapshot.
How has RPGLIFE performed recently?
RPGLIFE has returned +31.64% over 1 month, +49.99% over 3 months, and +15.45% over 12 months in the latest stored data.
Is this stock page investment advice?
No. This page is a data snapshot for screening and research. It is not buy, sell, legal, tax, or investment advice.
Financials and Ownership
Quarterly income statement
| Period | Revenue | EBITDA | PAT | EPS |
|---|---|---|---|---|
| 2026-03-31 | 176.89 cr | 46.33 cr | 29.90 cr | 18.08 |
| 2025-12-31 | 180.03 cr | 34.75 cr | 22.13 cr | 13.38 |
| 2025-09-30 | 186.22 cr | 43.57 cr | 36.85 cr | 22.28 |
| 2025-06-30 | 168.92 cr | 40.70 cr | 26.29 cr | 15.90 |
| 2025-03-31 | 143.09 cr | 140.45 cr | 117.35 cr | 70.96 |
| 2024-12-31 | 172.71 cr | 52.47 cr | 34.93 cr | 21.12 |
| 2024-09-30 | 172.21 cr | 20.57 cr | n/a | nan |
| 2024-06-30 | 165.42 cr | 41.44 cr | 26.76 cr | 16.18 |
Annual income statement
| Year | Revenue | EBITDA | PAT | EPS |
|---|---|---|---|---|
| 2026-03-31 | 707.52 cr | 176.57 cr | 115.17 cr | 69.64 |
| 2025-03-31 | 653.43 cr | 254.93 cr | 183.24 cr | 110.80 |
| 2024-03-31 | 577.48 cr | 135.36 cr | 87.66 cr | 53.01 |
| 2023-03-31 | 509.08 cr | 107.49 cr | 67.64 cr | 40.90 |
| 2022-03-31 | 443.15 cr | 89.35 cr | 51.48 cr | 31.13 |
Balance sheet
| Period | Assets | Cash | Debt | Equity |
|---|---|---|---|---|
| 2026-03-31 | 793.16 cr | 150.46 cr | 20.00 cr | 605.35 cr |
| 2025-03-31 | 657.81 cr | 28.70 cr | n/a | 530.53 cr |
| 2024-03-31 | 512.87 cr | 19.72 cr | 0.00 cr | 374.85 cr |
| 2023-03-31 | 419.35 cr | 24.82 cr | 0.01 cr | 307.60 cr |
| 2022-03-31 | 344.61 cr | 56.94 cr | 0.94 cr | 255.77 cr |
Cash flow
| Period | OCF | FCF | Cash change |
|---|---|---|---|
| 2026-03-31 | 56.50 cr | -8.86 cr | n/a |
| 2025-03-31 | 77.86 cr | 41.83 cr | n/a |
| 2024-03-31 | 94.36 cr | 25.13 cr | n/a |
| 2023-03-31 | 90.82 cr | 58.09 cr | n/a |
| 2022-03-31 | 64.75 cr | 40.80 cr | n/a |
Shareholding Trend
| Period | Promoter | FII/FPI | DII | MF | Retail | Pledge |
|---|---|---|---|---|---|---|
| 2026-03-31 | +72.95% | +0.87% | +7.45% | +0.04% | +18.73% | +0.00% |
| 2025-12-31 | +72.95% | +1.00% | +7.04% | +0.04% | +19.01% | +0.00% |
| 2025-09-30 | +72.95% | +1.11% | +6.70% | +3.20% | +19.24% | +0.00% |
| 2025-06-30 | +72.95% | +1.35% | +6.48% | +3.38% | +19.22% | +0.00% |
| 2025-03-31 | +72.95% | +1.45% | +6.14% | +3.53% | +19.46% | +0.00% |
| 2024-12-31 | +72.95% | +1.30% | +6.06% | +3.47% | +19.69% | +0.00% |
| 2024-09-30 | +72.81% | +1.35% | +5.45% | +2.67% | +20.39% | +0.00% |
| 2024-06-30 | +72.81% | +1.14% | +4.63% | +1.65% | +21.42% | +0.00% |
| 2024-03-31 | +72.81% | +0.89% | +4.19% | +1.47% | +22.11% | +0.00% |
| 2023-12-31 | +72.81% | +0.56% | +3.79% | +1.08% | +22.84% | +0.00% |
| 2023-09-30 | +72.81% | +0.46% | +3.59% | +0.82% | +23.14% | +0.00% |
| 2023-06-30 | +72.81% | +0.34% | +2.29% | +0.00% | +24.56% | n/a |
| 2023-03-31 | +72.81% | +0.38% | +2.12% | +0.00% | +24.69% | +0.00% |
| 2022-12-31 | +72.61% | +0.25% | +2.02% | +0.00% | +25.11% | +0.00% |
| 2022-09-30 | +72.61% | +0.08% | +2.04% | +0.00% | +25.27% | +0.00% |
| 2022-06-30 | +72.42% | +0.00% | +0.16% | n/a | n/a | +0.00% |
| 2022-03-31 | +72.07% | +0.00% | +0.13% | n/a | n/a | +0.00% |
| 2021-12-31 | +72.07% | +0.00% | +0.21% | n/a | n/a | +0.00% |
| 2021-09-30 | +72.07% | +0.00% | +0.03% | n/a | n/a | +0.00% |
| 2021-06-30 | +72.07% | +0.00% | +0.01% | n/a | n/a | +0.00% |
Industry Peers
| Symbol | Name | Mcap | PE | ROE | 1Y |
|---|---|---|---|---|---|
| SUNPHARMA | SUN PHARMACEUTICAL IND L | 470,725.53 cr | 40.938102 | +14.71% | +15.93% |
| DIVISLAB | DIVI S LABORATORIES LTD | 194,588.48 cr | 75.774332 | +16.19% | +9.60% |
| TORNTPHARM | TORRENT PHARMACEUTICALS L | 170,600.17 cr | 78.872017 | +17.18% | +43.04% |
| APOLLOHOSP | APOLLO HOSPITALS ENTER. L | 128,349.41 cr | 65.537894 | +21.03% | +23.05% |
| CIPLA | CIPLA LTD | 115,717.42 cr | 29.815932 | +11.79% | -2.81% |
| ZYDUSLIFE | ZYDUS LIFESCIENCES LTD | 115,022.61 cr | 22.938459 | +17.93% | +17.85% |
| LUPIN | LUPIN LIMITED | 114,980.65 cr | 21.532280 | +26.83% | +30.91% |
| MAXHEALTH | MAX HEALTHCARE INS LTD | 107,095.75 cr | 74.247785 | +14.33% | -9.67% |
Try these prompts
- Analyze RPG LIFE SCIENCES with valuation, momentum and industry peers
- Compare RPGLIFE with other Healthcare stocks
- Show small-cap stocks in Healthcare above 50DMA with positive 1M return
- Find Healthcare stocks with improving momentum and reasonable valuation
Related screen ideas
- View Healthcare stocks
- View small-cap stocks
- Find stocks above 50DMA
- Compare RPGLIFE with other Healthcare stocks
Data snapshot: 2026-07-21. Not investment advice.